文献速递水电解质与酸碱

严重低钠血症过度矫正风险(SHOR)评分的推导与验证

Derivation and Validation of a Novel Risk Score to Predict Overcorrection of Severe Hyponatremia: The Severe Hyponatremia Overcorrection Risk (SHOR) Score.
PubMed 文献 · Clin J Am Soc Nephrol · 2019-06-12

该研究基于加拿大渥太华一家三级医院2003至2015年就诊的623例血清钠<116 mmol/L的严重低钠血症患者,利用14项已发表标准定义过度矫正,通过潜在类别分析推导出SHOR评分,该评分与过度矫正状态显著相关(Spearman相关系数0.45,c统计量0.77),但外部验证队列中关联不显著(P=0.39),需进一步外部验证。

要点

  • SHOR评分基于基线因素预测严重低钠血症过度矫正,内部验证相关显著。
  • 外部验证队列中SHOR评分与过度矫正的关联不显著,需谨慎推广。
  • 低渗尿(4分)、意识水平下降(2分)、呕吐(2分)等为预测因子。

核心结论

  • 在严重低钠血症患者中,过度矫正常见且可通过基线信息预测,但SHOR评分需进一步外部验证后才能普遍使用。

研究设计与样本

  • 回顾性队列研究,纳入2003年1月1日至2015年12月31日加拿大渥太华一家三级医院急诊科就诊的血清钠(经血糖校正)<116 mmol/L的患者623例(平均初始值112 mmol/L,SD 3.2)。

主要发现

  • 无、不太可能、可能和明确过度矫正的患病率分别为72%、4%、10%和14%。
  • 过度矫正独立相关因素包括意识水平下降(2分)、呕吐(2分)、严重低钾血症(1分)、低渗尿(4分)、容量超负荷(-5分)、胸部肿瘤(-5分)、年龄(50岁以上每十年-1分)和初始钠水平(<110 mmol/L:4分;110-111 mmol/L:2分;112-113 mmol/L:1分)。
  • SHOR评分与过度矫正状态显著相关(Spearman相关系数0.45;95% CI 0.36至0.49),区分度平均二分类c统计量0.77(95% CI 0.73至0.81)。
  • 内部验证队列(n=119)中SHOR评分与过度矫正状态显著相关(P<0.001),外部验证队列(n=95)中不显著(P=0.39)。

关键数值与推荐

  • 过度矫正使用14项已发表标准确定。
  • SHOR评分各因素分值:意识水平下降2分,呕吐2分,严重低钾血症1分,低渗尿4分,容量超负荷-5分,胸部肿瘤-5分,年龄50岁以上每十年-1分,初始钠<110 mmol/L 4分、110-111 mmol/L 2分、112-113 mmol/L 1分。

临床怎么用

  • SHOR评分可用于识别严重低钠血症过度矫正高风险患者,但外部验证不显著,临床使用前需进一步验证。

局限性

  • 外部验证队列中SHOR评分与过度矫正的关联不显著,限制了其普遍适用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Osmotic demyelination syndrome is the most concerning complication of severe hyponatremia, occurring with an overly rapid rate of serum sodium correction. There are limited clinical tools to aid in identifying individuals at high risk of overcorrection with severe hyponatremia. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We identified all patients who presented to a tertiary-care hospital emergency department in Ottawa, Canada (catchment area 1.2 million) between January 1, 2003 and December 31, 2015, with serum sodium (corrected for glucose levels) <116 mmol/L. Overcorrection was determined using 14 published criteria. Latent class analysis measured the independent association of baseline factors with a consensus overcorrection status on the basis of the 14 criteria, and was summarized as a risk score, which was validated in two cohorts. RESULTS: A total of 623 patients presented with severe hyponatremia (mean initial value 112 mmol/L; SD 3.2). The prevalence of no, unlikely, possible, and definite overcorrection was 72%, 4%, 10%, and 14%, respectively. Overcorrection was independently associated with decreased level of consciousness (2 points), vomiting (2 points), severe hypokalemia (1 point), hypotonic urine (4 points), volume overload (-5 points), chest tumor (-5 points), patient age (-1 point per decade, over 50 years), and initial sodium level (<110 mmol/L: 4 points; 110-111 mmol/L: 2 points; 112-113 mmol/L: 1 point). These points were summed to create the Severe Hyponatremic Overcorrection Risk (SHOR) score, which was significantly associated with overcorrection status (Spearman correlation 0.45; 95% confidence interval, 0.36 to 0.49) and was discriminating (average dichotomized c-statistic 0.77; 95% confidence interval, 0.73 to 0.81). The internal (n=119) and external (n=95) validation cohorts had significantly greater use of desmopressin, which was significantly associated with the SHOR score. The SHOR score was significantly associated with overcorrection status in the internal (P<0.001) but not external (P=0.39) validation cohort. CONCLUSIONS: In patients presenting with severe hyponatremia, overcorrection was common and predictable using baseline information. Further external validation of the SHOR is required before generalized use.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Woodfine JD, Sood MM, MacMillan TE, et al. Derivation and Validation of a Novel Risk Score to Predict Overcorrection of Severe Hyponatremia: The Severe Hyponatremia Overcorrection Risk (SHOR) Score. Clin J Am Soc Nephrol. 2019. PMID: 31189541. doi:10.2215/CJN.12251018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。